Professor of Pediatrics, Director of Pediatric Diabetes Program, University of California, San Francisco
Eda Cengiz, MD, MHS
What is your presentation about?
This past decade ushered in many exciting new technologies aimed at helping people with diabetes to better manage the disease. Diabetes technology use has been shown to improve clinical outcomes and empower people with diabetes. Children and adolescents with diabetes have unique treatment challenges. Diabetes technology devices address the unmet clinical need for customized pediatric diabetes treatment (“one size does not fit all”). I will present highlights of diabetes technology trials and game changers in diabetes technology for the pediatric population.
What makes this topic important in 2022?
As the pace of diabetes technology innovation continues to race ahead, there are many new devices that are approved for pediatric use. I would like to present these new developments in diabetes technology and also share some updates regarding innovative technology devices that are on the horizon.
How did you become involved with this area of diabetes research or care?
I have been involved in diabetes technology research for over 15 years. The possibility of automating diabetes treatment by technology is fascinating.
What are you most looking forward to at the 82nd Scientific Sessions?
It is nice to join the meeting in person. I look forward to brainstorming new ideas, projects with colleagues.